Advertisement
Mentice appoints new CEO
Mentice has appointed Frans Venker as its new Chief Executive Officer, effective January 1, 2025.
Frans Venker succeeds Göran Malmberg, who has served the company for 17 years and will remain in an advisory role.
Frans Venker
With over 25 years of experience in the industry addressing the same or related medical needs and therapies as Mentice, Venker brings a wealth of expertise and a proven track record in driving innovation, operational excellence, and sustainable growth, states the company. Most recently, he led the Business Unit for Computed Tomography and Advanced Molecular Imaging at Philips based in the USA. Before this role, he was the Business Leader of image-guided Therapy for Philips North America and a member of the Philips North America Leadership Team and has served as Global Marketing Leader for Diagnostic X-Ray in Shanghai, China, in addition to various leadership positions in Europe.
“It is an honor to take on this role at such a crucial time for the company. I look forward to leading the extraordinarily talented team at Mentice to deliver value for patients, customers, employees, and shareholders while building on the strong foundation already in place,” said Frans Venker, looking forward to joining Mentice
Venker is a Dutch citizen and holds a Master of Science degree in Applied Physics from the University of Groningen and an Executive MBA degree from the Rotterdam School of Management.
Updated: December 11, 2024, 11:29 am
Published: December 1, 2024